Ribavirin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ribavirin. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Alopecia | 33% |
| Pruritus | 19% |
| Dermatitis | 16% |
| Dry skin | 13% |
| Rash | 8% |
| Sweating increased | 6% |
| Eczema | 5% |
| Vision blurred | 5% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Ribavirin tablets in combination with peginterferon alfa-2a are indicated for the treatment of adults with chronic hepatitis C virus infection who have compensated liver disease and have not been previously treated with interferon alpha. Patients in whom efficacy was demonstrated included patients with compensated liver disease and histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that is clinically stable (e.g., antiretroviral therapy not required or receiving stable antiretroviral therapy).
Medical disclaimer: Always consult a qualified healthcare professional about any medication.